FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

7534011000036100: Irinotecan Hydrochloride Trihydrate (Mayne Pharma) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) injection, 2 mL vial (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
195163011000036119 Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL concentrated injection, 2 mL vial en Synonym Inactive Case sensitive Australian Medicines Terminology module
195164011000036117 Irinotecan Hydrochloride Trihydrate (Mayne Pharma) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) concentrated injection, 2 mL vial (trade product unit of use) en Fully specified name Inactive Case sensitive Australian Medicines Terminology module
2958021000168117 Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module
2958031000168119 Irinotecan Hydrochloride Trihydrate (Mayne Pharma) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) injection, 2 mL vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has manufactured dose form injection true Inferred relationship Some
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial Is a trade product unit of use true Inferred relationship Some
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial Is a Irinotecan Hydrochloride Trihydrate (Mayne Pharma) true Inferred relationship Some
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial Is a irinotecan hydrochloride trihydrate 40 mg/2 mL injection, vial true Inferred relationship Some
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has manufactured dose form concentrated injection false Inferred relationship Some
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has unit of use vial true Inferred relationship Some 1542393790
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has Australian BoSS irinotecan hydrochloride trihydrate true Inferred relationship Some 1542393789
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has intended active ingredient irinotecan true Inferred relationship Some 1542393789
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has TPUU True Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial Inferred relationship Some 1
Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial has TPUU True Irinotecan Hydrochloride Trihydrate (Mayne Pharma) 40 mg/2 mL injection, 2 mL vial Inferred relationship Some 1

Reference Sets

Australian dialect reference set

Description inactivation indicator reference set

Trade product unit of use reference set

Back to Start